Auxi Therapeutics Sdn. Bhd., base in Kuala Lumpur, Malaysia, is specialized in CAR-T Cell Therapy against Immune-Related Malignancies.
Founded in 2019, Auxi Therapeutics Sdn Bhd is a company specializing in providing variety of T-cell-based immunotherapies for cancer treatment. With best-in-class capacity and capacity in both sales and marketing, AUXI support scientific endeavors through offering high-quality cancer treatment and services. As a fast-growing enterprise, the diverse portfolio of AUXI encompasses extensive services in individualized T-cell-based immunotherapies treatment and engineering together with iCARTab BioMed, one stop solution for healthcare services as well as medical travel tourism. With the mission of “Real Hope, Treat More” that aim to create a hope to cure and treat more the cancer patients, AUXI has strived to remain a real affordable & ease of accessible treatment for all cancer patients
The availability of such treatment in Malaysia also enable Auxi Therapeutics Sdn. Bhd. in providing similar treatment by cooperating with some leading hospitals in Kuala Lumpur for those patients in the South East Asian Region.
Get to know more about us at our AUXI THERAPEUTICS WEBSITE
Feel free to contact us with any question
